An end-to-end COVID-19 test system
An end-to-end, highly scalable solution to detect active COVID-19 infections
lower nasal swabs.
Choice of unsupervised
or supervised on-site
Authorized for use
in symptomatic and
(after receipt in the
to patient and
A flexible and scalable solution
Helix is helping communities and health systems safely navigate through this pandemic by leveraging our state-of-the-art CLIA / CAP lab to provide an end-to-end, highly scalable solution to detect active COVID-19 infections.
Simplified on-site operations
Our recently expanded EUA enables both supervised and unsupervised self-collection on-site—meaning no healthcare professional is required to be on-site—which helps education and employer partners significantly streamline their operations and decrease their collection costs.
High-sensitivity molecular testing
A recent report from the FDA comparing more than 75 other tests demonstrated that the Helix® COVID-19 Test is one of the most sensitive on the market.
Highly automated clinical laboratory
The Helix Laboratory, a CLIA/CAP facility with a demonstrated track record of powering high volume genomic projects, has a high-throughput, automated accessioning process and is scaling to 100,000 tests per day.
Beyond just testing
Helix is able to support its partners with additional services as needed, including a local and national courier service and insurance billing and reimbursement
Viral surveillance sequencing program
The Helix® COVID-19 Surveillance DashboardHelix and Illumina, with support from the CDC, are collaborating to augment national surveillance infrastructure in the US to track the emergence and prevalence of novel variants of SARS-CoV-2. Sequences are deposited regularly to GISAID and Genbank by the CDC. All B.1.1.7 variants are also reported to relevant public health departments for contact tracing efforts.
See dashboard >
Identifying B.1.1.7 in the United States
Interferon signaling and the severity of COVID-19
Saliva testing less sensitive than NPS in the community
Modeling the impact of COVID-19 surveillance testing
Genetics of COVID-19 pathophysiology
GWAS of severe COVID-19 symptoms
Predicted COVID-19 positivity based on symptoms
Contact us to learn more about our COVID-19 resources
Please note: we are not accepting orders from individuals at this time